ALK-Positive Renal Cell Carcinoma in a Large Series of Consecutively Resected Korean Renal Cell Carcinoma Patients
Recently, there have been a few reports of renal cell carcinoma (RCC) cases with anaplastic lymphoma kinase (ALK) gene fusion. In this study, we screened consecutively resected RCCs from a single institution for ALK protein expression by immunohistochemistry, and then we performed fluorescence in si...
Saved in:
Published in | Journal of pathology and translational medicine Vol. 47; no. 5; pp. 452 - 457 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
Korean Society of Pathologists, Korean Society for Cytopathology
01.10.2013
The Korean Society of Pathologists and The Korean Society for Cytopathology 대한병리학회 |
Subjects | |
Online Access | Get full text |
ISSN | 1738-1843 2383-7837 2092-8920 2383-7845 |
DOI | 10.4132/KoreanJPathol.2013.47.5.452 |
Cover
Loading…
Abstract | Recently, there have been a few reports of renal cell carcinoma (RCC) cases with anaplastic lymphoma kinase (ALK) gene fusion. In this study, we screened consecutively resected RCCs from a single institution for ALK protein expression by immunohistochemistry, and then we performed fluorescence in situ hybridization to confirm the ALK gene alteration in ALK immunohistochemistry-positive cases.
We screened 829 RCCs by ALK immunohistochemistry, and performed fluorescence in situ hybridization analysis using ALK dual-color break-apart rearrangement probe. Histological review and additional immunohistochemistry analyses were done in positive cases.
One ALK-positive case was found. Initial diagnosis of this case was papillary RCC type 2. This comprises 0.12% of all RCCs (1/829) and 1.9% of papillary RCCs (1/53). This patient was a 44-year-old male with RCC found during routine health check-up. He was alive without evidence of disease 12 years after surgery. The tumor showed a papillary and tubular pattern, and showed positivity for CD10 (focal), epithelial membrane antigen, cytokeratin 7, pan-cytokeratin, PAX-2, and vimentin.
We found the first RCC case with ALK gene rearrangement in Korean patients by ALK immunohistochemistry among 829 RCCs. This case showed similar histological and immunohistochemical features to those of previous adult cases with ALK rearrangement, and showed relatively good prognosis. |
---|---|
AbstractList | Background: Recently, there have been a few reports of renal cell carcinoma (RCC) cases with anaplastic lymphoma kinase (ALK) gene fusion. In this study, we screened consecutively resected RCCs from a single institution for ALK protein expression by immunohistochemistry, and then we performed fluorescence in situ hybridization to confirm the ALK gene alteration in ALK immunohistochemistry-positive cases. Methods: We screened 829 RCCs by ALK immunohistochemistry, and performed fluorescence in situ hybridization analysis using ALK dual-color break-apart rearrangement probe. Histological review and additional immunohistochemistry analyses were done in positive cases. Results: One ALK-positive case was found. Initial diagnosis of this case was papillary RCC type 2. This comprises 0.12% of all RCCs (1/829) and 1.9% of papillary RCCs (1/53). This patient was a 44-year-old male with RCC found during routine health check-up. He was alive without evidence of disease 12 years after surgery. The tumor showed a papillary and tubular pattern, and showed positivity for CD10 (focal), epithelial membrane antigen, cytokeratin 7, pan-cytokeratin, PAX-2, and vimentin. Conclusions: We found the first RCC case with ALK gene rearrangement in Korean patients by ALK immunohistochemistry among 829 RCCs. This case showed similar histological and immunohistochemical features to those of previous adult cases with ALK rearrangement, and showed relatively good prognosis. KCI Citation Count: 0 Recently, there have been a few reports of renal cell carcinoma (RCC) cases with anaplastic lymphoma kinase (ALK) gene fusion. In this study, we screened consecutively resected RCCs from a single institution for ALK protein expression by immunohistochemistry, and then we performed fluorescence in situ hybridization to confirm the ALK gene alteration in ALK immunohistochemistry-positive cases. We screened 829 RCCs by ALK immunohistochemistry, and performed fluorescence in situ hybridization analysis using ALK dual-color break-apart rearrangement probe. Histological review and additional immunohistochemistry analyses were done in positive cases. One ALK-positive case was found. Initial diagnosis of this case was papillary RCC type 2. This comprises 0.12% of all RCCs (1/829) and 1.9% of papillary RCCs (1/53). This patient was a 44-year-old male with RCC found during routine health check-up. He was alive without evidence of disease 12 years after surgery. The tumor showed a papillary and tubular pattern, and showed positivity for CD10 (focal), epithelial membrane antigen, cytokeratin 7, pan-cytokeratin, PAX-2, and vimentin. We found the first RCC case with ALK gene rearrangement in Korean patients by ALK immunohistochemistry among 829 RCCs. This case showed similar histological and immunohistochemical features to those of previous adult cases with ALK rearrangement, and showed relatively good prognosis. Recently, there have been a few reports of renal cell carcinoma (RCC) cases with anaplastic lymphoma kinase (ALK) gene fusion. In this study, we screened consecutively resected RCCs from a single institution for ALK protein expression by immunohistochemistry, and then we performed fluorescence in situ hybridization to confirm the ALK gene alteration in ALK immunohistochemistry-positive cases. We screened 829 RCCs by ALK immunohistochemistry, and performed fluorescence in situ hybridization analysis using ALK dual-color break-apart rearrangement probe. Histological review and additional immunohistochemistry analyses were done in positive cases. One ALK-positive case was found. Initial diagnosis of this case was papillary RCC type 2. This comprises 0.12% of all RCCs (1/829) and 1.9% of papillary RCCs (1/53). This patient was a 44-year-old male with RCC found during routine health check-up. He was alive without evidence of disease 12 years after surgery. The tumor showed a papillary and tubular pattern, and showed positivity for CD10 (focal), epithelial membrane antigen, cytokeratin 7, pan-cytokeratin, PAX-2, and vimentin. We found the first RCC case with ALK gene rearrangement in Korean patients by ALK immunohistochemistry among 829 RCCs. This case showed similar histological and immunohistochemical features to those of previous adult cases with ALK rearrangement, and showed relatively good prognosis. [PUBLICATION ABSTRACT] Recently, there have been a few reports of renal cell carcinoma (RCC) cases with anaplastic lymphoma kinase (ALK) gene fusion. In this study, we screened consecutively resected RCCs from a single institution for ALK protein expression by immunohistochemistry, and then we performed fluorescence in situ hybridization to confirm the ALK gene alteration in ALK immunohistochemistry-positive cases.BACKGROUNDRecently, there have been a few reports of renal cell carcinoma (RCC) cases with anaplastic lymphoma kinase (ALK) gene fusion. In this study, we screened consecutively resected RCCs from a single institution for ALK protein expression by immunohistochemistry, and then we performed fluorescence in situ hybridization to confirm the ALK gene alteration in ALK immunohistochemistry-positive cases.We screened 829 RCCs by ALK immunohistochemistry, and performed fluorescence in situ hybridization analysis using ALK dual-color break-apart rearrangement probe. Histological review and additional immunohistochemistry analyses were done in positive cases.METHODSWe screened 829 RCCs by ALK immunohistochemistry, and performed fluorescence in situ hybridization analysis using ALK dual-color break-apart rearrangement probe. Histological review and additional immunohistochemistry analyses were done in positive cases.One ALK-positive case was found. Initial diagnosis of this case was papillary RCC type 2. This comprises 0.12% of all RCCs (1/829) and 1.9% of papillary RCCs (1/53). This patient was a 44-year-old male with RCC found during routine health check-up. He was alive without evidence of disease 12 years after surgery. The tumor showed a papillary and tubular pattern, and showed positivity for CD10 (focal), epithelial membrane antigen, cytokeratin 7, pan-cytokeratin, PAX-2, and vimentin.RESULTSOne ALK-positive case was found. Initial diagnosis of this case was papillary RCC type 2. This comprises 0.12% of all RCCs (1/829) and 1.9% of papillary RCCs (1/53). This patient was a 44-year-old male with RCC found during routine health check-up. He was alive without evidence of disease 12 years after surgery. The tumor showed a papillary and tubular pattern, and showed positivity for CD10 (focal), epithelial membrane antigen, cytokeratin 7, pan-cytokeratin, PAX-2, and vimentin.We found the first RCC case with ALK gene rearrangement in Korean patients by ALK immunohistochemistry among 829 RCCs. This case showed similar histological and immunohistochemical features to those of previous adult cases with ALK rearrangement, and showed relatively good prognosis.CONCLUSIONSWe found the first RCC case with ALK gene rearrangement in Korean patients by ALK immunohistochemistry among 829 RCCs. This case showed similar histological and immunohistochemical features to those of previous adult cases with ALK rearrangement, and showed relatively good prognosis. |
Author | Nam, Kyung Han Moon, Kyung Chul Suh, Ja Hee Park, Jeong Whan Lee, Cheol |
AuthorAffiliation | 1 Department of Pathology, Seoul National University College of Medicine, Seoul, Korea 2 Kidney Research Institute, Medical Research Center, Seoul National University College of Medicine, Seoul, Korea |
AuthorAffiliation_xml | – name: 2 Kidney Research Institute, Medical Research Center, Seoul National University College of Medicine, Seoul, Korea – name: 1 Department of Pathology, Seoul National University College of Medicine, Seoul, Korea |
Author_xml | – sequence: 1 givenname: Cheol surname: Lee fullname: Lee, Cheol organization: Department of Pathology, Seoul National University College of Medicine, Seoul, Korea – sequence: 2 givenname: Jeong Whan surname: Park fullname: Park, Jeong Whan organization: Department of Pathology, Seoul National University College of Medicine, Seoul, Korea – sequence: 3 givenname: Ja Hee surname: Suh fullname: Suh, Ja Hee organization: Department of Pathology, Seoul National University College of Medicine, Seoul, Korea – sequence: 4 givenname: Kyung Han surname: Nam fullname: Nam, Kyung Han organization: Department of Pathology, Seoul National University College of Medicine, Seoul, Korea – sequence: 5 givenname: Kyung Chul surname: Moon fullname: Moon, Kyung Chul organization: Department of Pathology, Seoul National University College of Medicine, Seoul, Korea., Kidney Research Institute, Medical Research Center, Seoul National University College of Medicine, Seoul, Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24255633$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001813263$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNqNUl1rFDEUDVKx2-pfkEBffJkx3zNBEJbFj9oFS63PIZvJtGlnkzWZKfTfe3fXqi0--JJLyDnnnntzjtBBTNEjdEJJLShnb89S9jZ-ObfjdRpqRiivRVPLWkj2DM0Y0axqNSMHaEYb3la0FfwQHZVyQ4gSQpEX6JAJJqXifIbyfHlWnacSxnDn8YWPdsALP8BhswsxrS0OEVu8tPnK428-B19w6vEixeLdtGUN98CDy-g7vPf2bx0wHHwcy0v0vLdD8a9-1WP0_eOHy8Xnavn10-livqwceBurvuv1ynErqGp930puG9orqyQRK017TXQnmFeOcsGJbjmMqTrbNFqJ1ktgHqM3e92Ye3Prgkk27OpVMrfZzC8uT03LtGoEQN_voZtptfadA5vZDmaTw9rm-x3x8UsM1yBzZ3gLvTX702uT04_Jl9GsQ3Ewv40-TcVQoeBLZCMpQE-eQG_SlGFfOxRhnDWaA-r1345-W3n4OQDM9wCXUynZ98aFETactgbDYCgx27SYR2kx27QY0RhpIC2g8e6JxkOb_2H_BNqCygQ |
CitedBy_id | crossref_primary_10_1016_j_prp_2019_152669 crossref_primary_10_1016_j_prp_2025_155814 crossref_primary_10_3349_ymj_2020_61_3_262 crossref_primary_10_1097_MD_0000000000016702 crossref_primary_10_1002_gcc_22346 crossref_primary_10_1038_s41379_021_00737_6 crossref_primary_10_1097_PAP_0000000000000138 crossref_primary_10_1016_j_mpdhp_2016_01_005 crossref_primary_10_1097_PAS_0000000000000610 crossref_primary_10_1002_gcc_22382 crossref_primary_10_1038_s41379_020_0578_0 crossref_primary_10_3390_ijms23073995 crossref_primary_10_1016_j_eururo_2018_03_032 crossref_primary_10_1016_j_prp_2016_07_015 crossref_primary_10_1111_his_13185 crossref_primary_10_1016_j_modpat_2024_100536 crossref_primary_10_1186_s13000_019_0879_0 crossref_primary_10_1016_j_prp_2019_152651 crossref_primary_10_1111_his_13727 crossref_primary_10_1016_j_prp_2020_153286 crossref_primary_10_1186_s12885_018_4066_6 crossref_primary_10_1097_PAS_0000000000001476 crossref_primary_10_1111_pin_12592 crossref_primary_10_3390_cancers12010168 crossref_primary_10_1007_s13277_015_3977_y crossref_primary_10_1016_j_cancergen_2017_11_010 crossref_primary_10_3390_cancers12010085 crossref_primary_10_1016_j_prp_2016_07_004 crossref_primary_10_1007_s00428_020_02752_5 |
Cites_doi | 10.1016/j.semcancer.2011.09.005 10.1007/s00428-011-1127-5 10.1126/science.8122112 10.1097/JTO.0b013e31820b82e8 10.1002/cncr.27391 10.1200/JCO.2005.07.055 10.1056/NEJMoa1006448 10.1097/JTO.0b013e318274a83e 10.1016/j.prp.2011.07.001 10.4143/crt.2013.45.1.1 10.1097/CCO.0b013e328351c646 10.1038/modpathol.2012.107 10.1371/journal.pone.0018436 10.1038/modpathol.2010.213 10.1056/NEJMoa1007056 10.1016/j.lungcan.2011.11.008 10.1073/pnas.0609412103 10.1097/JTO.0b013e31821cfc73 10.1097/00000478-200111000-00003 10.1002/gcc.20839 10.1200/JCO.2008.21.5020 10.1038/nature07399 |
ContentType | Journal Article |
Copyright | Copyright Korean Society of Pathologists, Korean Society for Cytopathology Oct 2013 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology 2013 |
Copyright_xml | – notice: Copyright Korean Society of Pathologists, Korean Society for Cytopathology Oct 2013 – notice: 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology 2013 |
DBID | AAYXX CITATION NPM 3V. 7XB 8FK 8G5 ABUWG AFKRA AZQEC BENPR BVBZV CCPQU DWQXO GNUQQ GUQSH M2O MBDVC PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM ACYCR |
DOI | 10.4132/KoreanJPathol.2013.47.5.452 |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) ProQuest Central (purchase pre-March 2016) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest East & South Asia Database (NC LIVE) ProQuest One Community College ProQuest Central ProQuest Central Student Research Library Prep Research Library Research Library (Corporate) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Basic ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Central (Alumni Edition) ProQuest One Community College Research Library (Alumni Edition) ProQuest Central China East & South Asia Database ProQuest Central ProQuest One Academic UKI Edition ProQuest Central Korea ProQuest Research Library ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | PubMed Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2092-8920 2383-7845 |
EndPage | 457 |
ExternalDocumentID | oai_kci_go_kr_ARTI_829674 PMC3830992 3132815151 24255633 10_4132_KoreanJPathol_2013_47_5_452 |
Genre | Journal Article Feature |
GrantInformation_xml | – fundername: Seoul University Hospital grantid: 03-2010-009 |
GroupedDBID | 5-W 5GY 8G5 8JR 9ZL AAYXX ABDBF ABUWG ACUHS ADBBV ADRAZ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BENPR BPHCQ BVBZV CITATION DIK DWQXO EF. ESX GNUQQ GUQSH HYE KQ8 M2O M48 PGMZT RNS RPM TUS NPM OK1 3V. 7XB 8FK ACYCR AFKRA AZQEC BCNDV CCPQU GROUPED_DOAJ MBDVC PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI PRINS PROAC Q9U 7X8 5PM IPNFZ M~E RIG |
ID | FETCH-LOGICAL-c556t-fdf9bc3a4168ef853a71f6a6504b91f909d42e6c134309838436da779648e5bc3 |
IEDL.DBID | M48 |
ISSN | 1738-1843 2383-7837 |
IngestDate | Tue Nov 21 21:39:55 EST 2023 Thu Aug 21 18:04:39 EDT 2025 Fri Jul 11 06:54:05 EDT 2025 Mon Jun 30 02:44:05 EDT 2025 Thu Jan 02 22:12:28 EST 2025 Tue Jul 01 00:30:30 EDT 2025 Thu Apr 24 23:10:07 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | ALK Immunohistochemistry In situ hybridization, fluorescence Carcinoma, renal cell |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c556t-fdf9bc3a4168ef853a71f6a6504b91f909d42e6c134309838436da779648e5bc3 |
Notes | SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 G704-000333.2013.47.5.010 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.4132/KoreanJPathol.2013.47.5.452 |
PMID | 24255633 |
PQID | 1460232793 |
PQPubID | 1146335 |
PageCount | 6 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_829674 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3830992 proquest_miscellaneous_1469205751 proquest_journals_1460232793 pubmed_primary_24255633 crossref_citationtrail_10_4132_KoreanJPathol_2013_47_5_452 crossref_primary_10_4132_KoreanJPathol_2013_47_5_452 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2013-10-01 |
PublicationDateYYYYMMDD | 2013-10-01 |
PublicationDate_xml | – month: 10 year: 2013 text: 2013-10-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) – name: Seoul |
PublicationTitle | Journal of pathology and translational medicine |
PublicationTitleAlternate | Korean J Pathol |
PublicationYear | 2013 |
Publisher | Korean Society of Pathologists, Korean Society for Cytopathology The Korean Society of Pathologists and The Korean Society for Cytopathology 대한병리학회 |
Publisher_xml | – name: Korean Society of Pathologists, Korean Society for Cytopathology – name: The Korean Society of Pathologists and The Korean Society for Cytopathology – name: 대한병리학회 |
References | Mariño-Enríquez (10.4132/KoreanJPathol.2013.47.5.452_ref19) 2011; 50 Laurent (10.4132/KoreanJPathol.2013.47.5.452_ref6) 2009; 27 Azarova (10.4132/KoreanJPathol.2013.47.5.452_ref14) 2011; 21 Patard (10.4132/KoreanJPathol.2013.47.5.452_ref3) 2005; 23 Jung (10.4132/KoreanJPathol.2013.47.5.452_ref1) 2013; 45 Conklin (10.4132/KoreanJPathol.2013.47.5.452_ref24) 2013; 8 Eble (10.4132/KoreanJPathol.2013.47.5.452_ref2) 2004 Kwak (10.4132/KoreanJPathol.2013.47.5.452_ref10) 2010; 363 Sugawara (10.4132/KoreanJPathol.2013.47.5.452_ref21) 2012; 118 Kim (10.4132/KoreanJPathol.2013.47.5.452_ref15) 2011; 6 Chen (10.4132/KoreanJPathol.2013.47.5.452_ref9) 2008; 455 Morris (10.4132/KoreanJPathol.2013.47.5.452_ref5) 1994; 263 Butrynski (10.4132/KoreanJPathol.2013.47.5.452_ref11) 2010; 363 Wang (10.4132/KoreanJPathol.2013.47.5.452_ref7) 2011; 207 Debelenko (10.4132/KoreanJPathol.2013.47.5.452_ref18) 2011; 24 Paik (10.4132/KoreanJPathol.2013.47.5.452_ref16) 2011; 6 Kim (10.4132/KoreanJPathol.2013.47.5.452_ref22) 2011; 459 Singer (10.4132/KoreanJPathol.2013.47.5.452_ref4) 2012; 24 Cerchietti (10.4132/KoreanJPathol.2013.47.5.452_ref13) 2011; 6 Edge (10.4132/KoreanJPathol.2013.47.5.452_ref23) 2010 Sukov (10.4132/KoreanJPathol.2013.47.5.452_ref20) 2012; 25 Galkin (10.4132/KoreanJPathol.2013.47.5.452_ref12) 2007; 104 Paik (10.4132/KoreanJPathol.2013.47.5.452_ref17) 2012; 76 Cook (10.4132/KoreanJPathol.2013.47.5.452_ref8) 2001; 25 21587085 - J Thorac Oncol. 2011 Aug;6(8):1359-66 17185414 - Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):270-5 21494621 - PLoS One. 2011 Apr 08;6(4):e18436 20979469 - N Engl J Med. 2010 Oct 28;363(18):1693-703 19636007 - J Clin Oncol. 2009 Sep 1;27(25):4211-6 21213368 - Genes Chromosomes Cancer. 2011 Mar;50(3):146-53 8122112 - Science. 1994 Mar 4;263(5151):1281-4 23196275 - J Thorac Oncol. 2013 Jan;8(1):45-51 23613665 - Cancer Res Treat. 2013 Mar;45(1):1-14 18923524 - Nature. 2008 Oct 16;455(7215):971-4 21258247 - J Thorac Oncol. 2011 Mar;6(3):466-72 21076462 - Mod Pathol. 2011 Mar;24(3):430-42 22743654 - Mod Pathol. 2012 Nov;25(11):1516-25 22129856 - Lung Cancer. 2012 Jun;76(3):403-9 21945349 - Semin Cancer Biol. 2011 Oct;21(4):267-75 11684952 - Am J Surg Pathol. 2001 Nov;25(11):1364-71 21773754 - Virchows Arch. 2011 Sep;459(3):299-306 21855232 - Pathol Res Pract. 2011 Sep 15;207(9):587-91 22343386 - Curr Opin Oncol. 2012 May;24(3):284-90 15837991 - J Clin Oncol. 2005 Apr 20;23(12):2763-71 20979472 - N Engl J Med. 2010 Oct 28;363(18):1727-33 22252991 - Cancer. 2012 Sep 15;118(18):4427-36 |
References_xml | – volume: 21 start-page: 267 year: 2011 ident: 10.4132/KoreanJPathol.2013.47.5.452_ref14 publication-title: Semin Cancer Biol doi: 10.1016/j.semcancer.2011.09.005 – volume: 459 start-page: 299 year: 2011 ident: 10.4132/KoreanJPathol.2013.47.5.452_ref22 publication-title: Virchows Arch doi: 10.1007/s00428-011-1127-5 – volume-title: AJCC cancer staging manual year: 2010 ident: 10.4132/KoreanJPathol.2013.47.5.452_ref23 – volume: 263 start-page: 1281 year: 1994 ident: 10.4132/KoreanJPathol.2013.47.5.452_ref5 publication-title: Science doi: 10.1126/science.8122112 – volume: 6 start-page: 466 year: 2011 ident: 10.4132/KoreanJPathol.2013.47.5.452_ref16 publication-title: J Thorac Oncol doi: 10.1097/JTO.0b013e31820b82e8 – volume: 118 start-page: 4427 year: 2012 ident: 10.4132/KoreanJPathol.2013.47.5.452_ref21 publication-title: Cancer doi: 10.1002/cncr.27391 – start-page: 12 volume-title: Pathology and genetics of tumours of the urinary system and male genital organs year: 2004 ident: 10.4132/KoreanJPathol.2013.47.5.452_ref2 – volume: 23 start-page: 2763 year: 2005 ident: 10.4132/KoreanJPathol.2013.47.5.452_ref3 publication-title: J Clin Oncol doi: 10.1200/JCO.2005.07.055 – volume: 363 start-page: 1693 year: 2010 ident: 10.4132/KoreanJPathol.2013.47.5.452_ref10 publication-title: N Engl J Med doi: 10.1056/NEJMoa1006448 – volume: 8 start-page: 45 year: 2013 ident: 10.4132/KoreanJPathol.2013.47.5.452_ref24 publication-title: J Thorac Oncol doi: 10.1097/JTO.0b013e318274a83e – volume: 207 start-page: 587 year: 2011 ident: 10.4132/KoreanJPathol.2013.47.5.452_ref7 publication-title: Pathol Res Pract doi: 10.1016/j.prp.2011.07.001 – volume: 45 start-page: 1 year: 2013 ident: 10.4132/KoreanJPathol.2013.47.5.452_ref1 publication-title: Cancer Res Treat doi: 10.4143/crt.2013.45.1.1 – volume: 24 start-page: 284 year: 2012 ident: 10.4132/KoreanJPathol.2013.47.5.452_ref4 publication-title: Curr Opin Oncol doi: 10.1097/CCO.0b013e328351c646 – volume: 25 start-page: 1516 year: 2012 ident: 10.4132/KoreanJPathol.2013.47.5.452_ref20 publication-title: Mod Pathol doi: 10.1038/modpathol.2012.107 – volume: 6 start-page: e18436 year: 2011 ident: 10.4132/KoreanJPathol.2013.47.5.452_ref13 publication-title: PLoS One doi: 10.1371/journal.pone.0018436 – volume: 24 start-page: 430 year: 2011 ident: 10.4132/KoreanJPathol.2013.47.5.452_ref18 publication-title: Mod Pathol doi: 10.1038/modpathol.2010.213 – volume: 363 start-page: 1727 year: 2010 ident: 10.4132/KoreanJPathol.2013.47.5.452_ref11 publication-title: N Engl J Med doi: 10.1056/NEJMoa1007056 – volume: 76 start-page: 403 year: 2012 ident: 10.4132/KoreanJPathol.2013.47.5.452_ref17 publication-title: Lung Cancer doi: 10.1016/j.lungcan.2011.11.008 – volume: 104 start-page: 270 year: 2007 ident: 10.4132/KoreanJPathol.2013.47.5.452_ref12 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0609412103 – volume: 6 start-page: 1359 year: 2011 ident: 10.4132/KoreanJPathol.2013.47.5.452_ref15 publication-title: J Thorac Oncol doi: 10.1097/JTO.0b013e31821cfc73 – volume: 25 start-page: 1364 year: 2001 ident: 10.4132/KoreanJPathol.2013.47.5.452_ref8 publication-title: Am J Surg Pathol doi: 10.1097/00000478-200111000-00003 – volume: 50 start-page: 146 year: 2011 ident: 10.4132/KoreanJPathol.2013.47.5.452_ref19 publication-title: Genes Chromosomes Cancer doi: 10.1002/gcc.20839 – volume: 27 start-page: 4211 year: 2009 ident: 10.4132/KoreanJPathol.2013.47.5.452_ref6 publication-title: J Clin Oncol doi: 10.1200/JCO.2008.21.5020 – volume: 455 start-page: 971 year: 2008 ident: 10.4132/KoreanJPathol.2013.47.5.452_ref9 publication-title: Nature doi: 10.1038/nature07399 – reference: 23613665 - Cancer Res Treat. 2013 Mar;45(1):1-14 – reference: 8122112 - Science. 1994 Mar 4;263(5151):1281-4 – reference: 19636007 - J Clin Oncol. 2009 Sep 1;27(25):4211-6 – reference: 21076462 - Mod Pathol. 2011 Mar;24(3):430-42 – reference: 21213368 - Genes Chromosomes Cancer. 2011 Mar;50(3):146-53 – reference: 21855232 - Pathol Res Pract. 2011 Sep 15;207(9):587-91 – reference: 22743654 - Mod Pathol. 2012 Nov;25(11):1516-25 – reference: 21773754 - Virchows Arch. 2011 Sep;459(3):299-306 – reference: 21587085 - J Thorac Oncol. 2011 Aug;6(8):1359-66 – reference: 23196275 - J Thorac Oncol. 2013 Jan;8(1):45-51 – reference: 20979472 - N Engl J Med. 2010 Oct 28;363(18):1727-33 – reference: 17185414 - Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):270-5 – reference: 15837991 - J Clin Oncol. 2005 Apr 20;23(12):2763-71 – reference: 11684952 - Am J Surg Pathol. 2001 Nov;25(11):1364-71 – reference: 18923524 - Nature. 2008 Oct 16;455(7215):971-4 – reference: 21258247 - J Thorac Oncol. 2011 Mar;6(3):466-72 – reference: 22129856 - Lung Cancer. 2012 Jun;76(3):403-9 – reference: 21945349 - Semin Cancer Biol. 2011 Oct;21(4):267-75 – reference: 20979469 - N Engl J Med. 2010 Oct 28;363(18):1693-703 – reference: 22252991 - Cancer. 2012 Sep 15;118(18):4427-36 – reference: 22343386 - Curr Opin Oncol. 2012 May;24(3):284-90 – reference: 21494621 - PLoS One. 2011 Apr 08;6(4):e18436 |
SSID | ssj0064460 ssj0001453649 |
Score | 2.0798368 |
Snippet | Recently, there have been a few reports of renal cell carcinoma (RCC) cases with anaplastic lymphoma kinase (ALK) gene fusion. In this study, we screened... Background: Recently, there have been a few reports of renal cell carcinoma (RCC) cases with anaplastic lymphoma kinase (ALK) gene fusion. In this study, we... |
SourceID | nrf pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 452 |
SubjectTerms | Genes Original Patients Pediatrics Studies 병리학 |
SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZoKyEuCMRroSAjuHq7iR9xuKBStSptqVYVlXqzHD9gu1un7KNS_z0zSXbLogpxSQ7xWHZmPPONPZ4h5KMVbjCIumKc-4IJ5xWrooys8oXC6rZWN7fSvp2qw3NxdCEvug23WRdWudSJjaL2tcM98h1Y0WBechCnz9e_GFaNwtPVroTGBtkCFaxBzre-7J8Oz-52WYTkqsHAYJo4K8Ade0g-gKYA3Z3vjGsAZukSa__WeAyR8b4o-rIvZL5mpjbSNN6HQP8OpPzDMh08IY87SEl3Wxl4Sh6E9IxMd0-O2bCJyLoJ9Cxgi70wgQcWD0r1laWjRC09wUhwintkYUbrSLGAZ3ALpJrcUozLc4BJ6XEzh_v7GbapWWfPyfnB_ve9Q9bVV2BOSjVn0ceyctwCJtMhgt22RRaVBcwmqjKL5aD0Ig_KZVzwQam5Flx5W-DlVR0kUL4gm6lO4RWhIq-8thkWLYtAoy1wqgJfyAcPCCbEHvm0_J3GdcnHsQbGxIATgrww7TyOhg0vDPLCiMJIA7zoEbEivm5zcPwf2Xvgmxm7kcEc2vj-UZvx1ICn8NXovFSF6JHtJVdNt3hn5k7UoIvVZ1h2eJZiU6gXTZsyR6yb9cjLVghWY0MvTioO1MWaeKwa4HDWv6TRzya1NwgpQPb89b-H9YY8wpm2MYXbZHM-XYS3gI3m1btuAfwGVdQOpA priority: 102 providerName: ProQuest |
Title | ALK-Positive Renal Cell Carcinoma in a Large Series of Consecutively Resected Korean Renal Cell Carcinoma Patients |
URI | https://www.ncbi.nlm.nih.gov/pubmed/24255633 https://www.proquest.com/docview/1460232793 https://www.proquest.com/docview/1469205751 https://pubmed.ncbi.nlm.nih.gov/PMC3830992 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001813263 |
Volume | 47 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Journal of Pathology and Translational Medicine, 2013, 47(5), , pp.452-457 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-NTZp4QXwTGJURvCY0sRMnvKAxbRrbOlUTlfZmObEN1UoCaYvYf89dvkRRHyZekgf7LPvubP_OPt8BvNOiGI9dmvucG-mLwiR-7mLn50YmlN1Wp82rtMllcjoTZ9fx9Q704Qk6Bi63mnaUT2pWL4LfP28_4oRH_BrgEhy9P68QX5VnU00HieStxQMhgzgQMa7Ne7hFJWSVTcRwvYAYoH0-LHG2U8KTfXh7h8YocLCgkF2cb-xi98rabQOo__pZ_rVxnTyEBx3iZIetijyCHVs-hv1Jd6f-BOrDi3N_2vhu_bLsylLlI7vAD6UZKqvvms1LptkF-YwzOk2zS1Y5Rqk-bbEmqsUtIw--AtEra0e2vZ1pG8R1-RRmJ8dfjk79LhODX-BwV74zLssLrpGVqXW4w2sZukQjuhN5FrpsnBkR2aQIueDjLOXI0sRoSc9cUxsj5TPYLavSvgAmotykOqT0Zg5pUs0jmaPVZKxBrGOdBx96zqqiC1NO2TIWCs0VkpDakJAiCSkhVaxQQh6IgfhHG63jbmRvUITqppgrirZN_6-VuqkV2hSfVRpliRQeHPQCVr2Wkt2EmCfCNQ6bGIpxgtKtiy5ttW7qZBGh4tCD560-DH3r1ckDuaEpQwXqzmZJOf_WBAHnKXI6i17-N-UruE9MaB0TD2B3Va_tawRYq3wEe5-OL6dXo-aAYtRMnVFzDvYHaLEnqA |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED9tnQS8IBBfhQFGwGO6xnacBAmhMTa1a1dV0ybtzXMSG0pLMvoB2j_F38hd0nQUTYiXvSQP9lm27-z7nX2-A3hjZNpuuyjxhMhCT6aZ8hIXOC_JQkXZbU1Uvko7GqjOqTw8C8424Ff9FobcKus9sdyosyKlM_IdXNGoXjiK04eL7x5ljaLb1TqFRiUWPXv5E0222fvuJ-TvW84P9k_2Ot4yq4CXBoGaey5zcZIKg0gksg61lQl9pwwiFZnEvovbcSa5VakvpGjHkYikUJkJ6clmZAOkxHY3YUvSi9YGbH3cHwyPr051ZCBUiblRFQovRPPvFrzGnQl1Bd8ZFwgE86-Ua7igaw9ftGTYCloy4GtqcTOfuusQ79-Om39owoN7cHcJYdluJXP3YcPmD2C62-95w9ID7Idlx5Zq7NkJfihZUV58M2yUM8P65HnO6EzOzljhGCUMtemCqCaXjPwAU8TArFeO4fp2hlUo2NlDOL2RmX8EjbzI7RNgkidZZHxKkuaQJjIoGQnaXpnNEDFZ14R39XTqdBnsnHJuTDQaPcQLXY3jcFjyQhMvtAx1oJEXTZAr4osq5sf_kb1CvulxOtIUs5v-nws9nmq0TLo64rEKZRO2a67q5WYx01eijU2sinGZ092NyW2xKOvEnLC134THlRCs-kZWY6AEUodr4rGqQN1ZL8lHX8pQ4iikaCLwp__u1ku43Tk56ut-d9B7Bndo1JU_4zY05tOFfY64bJ68WC4GBuc3vf5-A09ISnk |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1JbxMxFLbaVKq4sIgtUMAIOE6S8TYzSAh1IWqaUEWIVlUvZsZjQ0mYKVlA5afxV_gzvDdLSqoKcemBy8zBfpaXz2-xn98j5HksTKfjwsTjPA08YVLlJU46L0kDhdlt47B4lfZ2X-0eiL0jebRCftZvYdCtsuaJBaNOc4Nn5G3Y0SBeGMCp7Sq3iOFO9_XpVw8zSOFNa51Oo4RI3559B_Nt-qq3A2v9grHum_fbu16VYcAzUqqZ51IXJYbHoJWE1oHkigPfqRi0FpFEvos6USqYVcbngneikIeCqzQO8PlmaCVQQrurZC1UoWQNsrZ1uHV8eH7CIyRXhf4NYpF7AZiC6-QZcCmQG6w9ykEpzD5j3uEcr0B83hJBS7aEZEsicjWbuMu034tOnH9Ixe4N8quez9IZZtSaz5KW-XEh1OT_OeE3yfVKWaeb5e66RVZsdptMNgd9b1j4un2z9J3FGtt2DB9My5TlX2J6ktGYDtDHnuLpo53S3FFMjWrNHKnGZxQ9Hg1o-7RfrNDl7QzLoLfTO-TgSoZ5lzSyPLP3CRUsScPYx3RwDmjCGJYkASsztSnohtY1ycsaLNpUYd0xu8hYg3mHSNPlOPaGBdI0Ik2LQEsNSGsSsSA-LaOb_BvZU0ClHpkTjdHJ8f8x16OJBhusp0MWqUA0yUYNK12xxak-xxQ0sSgGhoa3VHFm83lRJ2JoRfhNcq-E-KJvaB9LxYE6WAL_ogJ2Z7kkO_lUBE2HLQjGEHvw9249IesAcj3o7fcfkms46NJxc4M0ZpO5fQQK6Cx5XO10Sj5cNdZ_A9ORlcI |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=ALK-Positive+Renal+Cell+Carcinoma+in+a+Large+Series+of+Consecutively+Resected+Korean+Renal+Cell+Carcinoma+Patients&rft.jtitle=The+Korean+journal+of+pathology&rft.au=Lee%2C+Cheol&rft.au=Park%2C+Jeong+Whan&rft.au=Suh%2C+Ja+Hee&rft.au=Nam%2C+Kyung+Han&rft.date=2013-10-01&rft.pub=The+Korean+Society+of+Pathologists+and+The+Korean+Society+for+Cytopathology&rft.issn=1738-1843&rft.eissn=2092-8920&rft.volume=47&rft.issue=5&rft.spage=452&rft.epage=457&rft_id=info:doi/10.4132%2FKoreanJPathol.2013.47.5.452&rft_id=info%3Apmid%2F24255633&rft.externalDocID=PMC3830992 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1738-1843&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1738-1843&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1738-1843&client=summon |